[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
November 7, 2001

A Meta-analysis of Hormone Replacement Therapy for Fracture Prevention—Reply

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor

JAMA. 2001;286(17):2096-2097. doi:10.1001/jama.286.17.2091

In Reply: Dr Altman is correct about the differences between allocation concealment and double-blinding, which we, unfortunately, did not clearly differentiate. However, 18 of the 20 studies were placebo-controlled. In placebo-controlled trials it is unlikely that allocation is unconcealed. Only 1 of the remaining studies described the randomization process, which used sealed envelopes.1 Envelopes are often judged an "adequate" method of concealed allocation.2 However, envelopes can be tampered with, as demonstrated in a surgical trial in which 44% of patients allocated using envelopes had suspected spoiled randomization envelopes.3 Importantly, the RRs between placebo and nonplacebo trials were not materially different.

First Page Preview View Large
First page PDF preview
First page PDF preview
×